论文部分内容阅读
目的:观察普米克令舒、博利康尼治疗小儿喘息性疾病急性发作疗效观察。方法:两组均根据病情给予肾上腺皮质激素口服或静脉滴注治疗及抗感染、吸氧等,实验组入院后即予以博利康尼雾化液加普米克令舒雾化液加2 m l生理盐水,以6 L/m in氧气为动力驱动喷雾器联合雾化吸入。对照组给予传统疗法即β2受体兴奋剂口服或茶碱类静脉滴注。结果:两组有效率比较有统计学差异(P<0.05)。结论:在小儿喘息性疾病急性发作期,利用氧气做动力,雾化吸入普米克令舒和博利康尼能迅速缓解症状,是一种安全、有效、方便的用药方案。
Objective: To observe the curative effect of pulmicort and brivaconi in the treatment of acute attack of asthmatic children. Methods: Both groups were given oral or intravenous infusion of corticosteroids and anti-infection, oxygen, etc. according to the condition. After the admission, the patients in the experimental group were treated with Boli Kang Ni aerosol solution plus pulmicort respirator solution plus 2 ml of normal saline , 6 L / m in oxygen-powered sprayer combined with inhalation. The control group was given traditional therapy, ie β2 receptor agonist oral or theophylline intravenous infusion. Results: There was significant difference between the two groups (P <0.05). Conclusion: It is safe, effective and convenient to use propofol and propolis as pulverizers to inhale pulmicort and braconidin to relieve the symptoms quickly during the acute attack of asthmatic children.